Answers are grounded in this paper and cite their sources.
Magnetic resonance imaging (MRI), a technique that has had a truly revolutionary impact on many areas of clinical medicine,1is starting to be appreciated by the dermatologic community. In this issue of theArchives, Truhan and Filipek2describe central nervous system MRI findings in patients with neurofibromatosis, tuberosclerosis, and Sturge-Weber syndrome. This is a comprehensive and well-written review on the subject. However, as the authors point out, in the majority of neurocutaneous syndromes, "consistent characteristic CNS findings by MRI have not yet been described."2For example, central nervous system MRI findings in patients with hypomelanosis of Ito are still poorly characterized and are inconsistent.3,4The use of MRI surface coils permits direct evaluation and characterization of dermatologic conditions by MR techniques. The evaluation of cutaneous diseases by MR techniques can be subdivided into three areas: (1) the evaluation of skin tumors by MRI using standard commercially
No takes yet. Share an insight, caveat, or question.
Alexander Zemtsov (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: